Gly-MCA was orally administered every day for 8 weeks (10 mg/ kg of body weight). Reduced lipid accumulation, inflammatory response (in injury markers, ALT and AST), and collagen deposition in NAFLD and NASH models. Lower liver endoplasmic reticulum stress and proinflammatory cytokine production (97). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.